10 Firms Fall Amid Disappointing Earnings Performance

Wall Street’s main indices all finished in the green territory on Tuesday, buoyed by news that the US is set to temporarily delay taxes levied on select goods from Canada and Mexico to make way for a potential negotiation.

The Dow Jones inched up by 0.30 percent, while the S&P 500 and Nasdaq both jumped 0.72 percent and 1.35 percent, respectively.

Meanwhile, 10 companies bucked an overall positive market sentiment, leading declines mostly due to disappointing earnings performance in the past quarter. This article details the reasons behind their poor performance.

To come up with Tuesday’s biggest losers, we only considered the companies with $2 billion in market capitalization and $5 million in daily trading volume.

A stock market chart. Photo by Arturo A on Pexels

10. elf Beauty Inc. (NYSE:ELF)

Shares of cosmetics giant elf Beauty saw its share prices drop for a third day on Tuesday, losing 5.38 percent to close at $88.44 apiece amid concerns over its January sales data.

In a report by Nielsen, elf Beauty reported a 2-percent decline in January sales including sales from Amazon, and a decline of 7 percent without sales from the e-commerce giant.

At 4:30 pm on Thursday, investors will be closely watching out for the release of the company’s third-quarter performance for fiscal year 2025, as well as indications about its outlook for the full year.

According to earlier comments from analysts, elf Beauty’s sales remain muted due to pressure in the cosmetics category, as the company seeks to increase its market share.

9. Centene Corporation (NYSE:CNC)

Healthcare company Centene Corp. dropped its share prices by 5.45 percent on Tuesday to end at $61.29 per share as investor sentiment was dampened by higher costs tied to its Medicaid plans, overshadowing better-than-expected earnings performance during the fourth quarter of 2024.

According to reports, as states redetermined the eligibility for Medicaid plans following the pandemic-era federal policy, healthier individuals were dropped from the list, leaving those who require more medical services which in turn added to insurers’ costs. Centene’s medical loss ratio settled at 89.6 percent during the period.

For 2025, Centene maintained its adjusted earnings per share (EPS) forecast of $7.25, but increased its annual premium and service revenue range to between $158 billion to $160 billion.